Qin, Qian
Sheffield, Hollie
Taasan, Sean M.
Wang, Andrew Z.
Zhang, Tian
Article History
Received: 4 November 2023
Accepted: 8 November 2023
First Online: 21 November 2023
Declarations
:
: Not applicable.
: QQ: Advisory board/consultant - Exelixis; AZW: Founder/stock options - Capio Biosciences, Archimmune Therapeutics; TZ: PI/research funding - Novartis, Merck, Regeneron, Mirati Therapeutics, Janssen, Astra Zeneca, Pfizer, Astellas, Eli Lilly, Tempus, ALX Oncology; Advisory Board/Consultant – Merck, Exelixis, Sanofi-Aventis, Janssen, Astra Zeneca, Pfizer, Amgen, BMS, Pharmacyclics, SeaGen, QED Therapeutics, Eisai, Aveo, Eli Lilly, Bayer, MJH Associates, Vaniam, Aptitude Health, PeerView, Aravive, Caris; HS & SMT: None.